Compare DLX & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLX | ENOV |
|---|---|---|
| Founded | 1915 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Fluid Controls |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 1994 | 2008 |
| Metric | DLX | ENOV |
|---|---|---|
| Price | $25.27 | $26.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $23.00 | ★ $47.38 |
| AVG Volume (30 Days) | 372.3K | ★ 884.8K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.99% | N/A |
| EPS Growth | ★ 52.54 | N/A |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $2,133,200,000.00 | N/A |
| Revenue This Year | $1.35 | $6.36 |
| Revenue Next Year | $1.30 | $5.31 |
| P/E Ratio | $33.12 | ★ N/A |
| Revenue Growth | ★ 0.54 | N/A |
| 52 Week Low | $13.61 | $21.00 |
| 52 Week High | $32.07 | $36.82 |
| Indicator | DLX | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 31.29 | 57.29 |
| Support Level | $18.25 | $25.98 |
| Resistance Level | $28.59 | $26.72 |
| Average True Range (ATR) | 1.32 | 1.48 |
| MACD | -0.70 | 0.22 |
| Stochastic Oscillator | 2.17 | 68.61 |
Deluxe Corp is principally a payments and data company. Its reportable segments are: Merchant Services, B2B Payments, Data Solutions, and Print. Maximum revenue is derived from its Print segment, which provides printed personal and business checks, business essentials, as well as branded promotional, print, apparel, and digital storefront solutions. The Merchant Services segment provides electronic credit and debit card authorization, payment systems, and processing services. The B2B segment offers treasury management solutions, integrated accounts payable disbursements, and fraud and security services, and the Data Solutions segment offers data, analytics, and marketing services, as well as financial institution profitability reporting and business incorporation services.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.